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Human papillomavirus type 16 (HPV-16) is the most common papillomavirus genome found in human cervical cancers
and its DNA is capable of immortalizing primary keratinocytes in vitro. When expressed by their native promoter, two
separate HPV-16 oncogenes, E6 and E7, cooperate to immortalize primary human keratinocytes. Early HPV cervical lesions
express abundant amounts of E5-specific RNA, and using a quantitative keratinocyte immortalization assay, we demonstrate
here that E5 can act in cis to increase (4–10 fold) the efficiency of cellular immortalization by E6/E7. These results suggest
that the expression of the HPV-16 E5 gene may play a role in the pathogenesis of early HPV infections by potentiating the
effects of E6/E7. q 1996 Academic Press, Inc.
Specific human papillomavirus (HPV) types are associ- tial of the viral genome (18) and it is believed that this
ated with genital neoplasias and appear to play a critical effect derives from consequent alterations in the expres-
role in the development of cervical cancer. HPV types sion of E6/E7.
6 and 11 are found in low-grade, premalignant lesions The HPV-16 E5 gene encodes an 83 amino acid poly-
(cervical intraepithelial neoplasia) and most commonly peptide and can transform rodent fibroblasts (19–22).
in benign genital warts (1, 2). In contrast, HPV types 16 Although E5 is unable to immortalize keratinocytes, it
and 18 are commonly associated with both premalignant does extend the in vitro proliferative life of these cells
disease (cervical intraepithelial neoplasia) of all grades (20), and the E5 gene from both animal and human papil-
as well as with malignant tumors (3–5). lomaviruses exhibits mitogenic activity (20, 23, 24). The
Parallel to their observed in vivo behavior, HPV-16 HPV-16 E5 protein has recently been shown to cooperate
and -18, but not HPV-6 or -11, can immortalize primary with the HPV-16 E7 protein to induce proliferation of 3T3
human keratinocytes and induce altered differentiation cells (25) and transform baby rat kidney cells (26). The
(6–9). In the context of the intact HPV-16 genome, both HPV-16 E5 protein was also found to stimulate expres-
the E6 and E7 genes are required for efficient cellular sion from the HPV-16 URR in 3T3 cells (25). Expression
immortalization (10 – 12). However, when expressed by of the HPV-16 E5 gene in human keratinocytes has been
an LTR promoter in retroviruses, the E7 gene is indepen- shown to reduce gap junctional cell–cell communication,
dently capable of immortalizing human keratinocytes, al- perhaps rendering cells insensitive to normal growth reg-
though with a lower frequency than that observed for ulatory signals and thus more susceptible to the effects
both E6 and E7 (13). As described previously, the prod- of the HPV E6 and E7 oncogenes (27).
ucts of the E6 and E7 genes bind to critical cell regulatory
Concomitant with the stimulation of cell growth, E5
proteins. E6 binds to p53 and reduces its stability (14,
inhibits the down-regulation of the epidermal growth fac-
15) while E7 binds and alters the functions of proteins
tor (EGFR) in the presence of ligand (20). The inhibition
of the retinoblastoma family, namely the retinoblastoma
of receptor degradation does not occur at the membraneprotein (pRB) and p107 (16, 17). It is anticipated that
(where internalization is normal) but rather in the endoso-additional early HPV genes may regulate either the ex-
mal compartment, and this inhibition of degradation re-pression or biological effects of the E6/E7 proteins. For
sults in a two- to fivefold increase in EGFR on the kera-example, interruption of either the E1 or E2 gene of HPV-
tinocyte surface. There is also an increase in EGFR phos-16 has been shown to increase the transforming poten-
phorylation which is greater than can be accounted for
by the increase in EGFR number. E5 biologic function
appears to be mediated in part by its ability to bind to1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (202) 687-5285. a subunit of the vacuolar ATPase (28), resulting in the
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TABLE 1inhibition of endosomal acidification (29), which is im-
portant for EGFR degradation (30). In agreement with this Immortalization of Human Keratinocytes
hypothesis for an indirect mechanism of EGFR activation
No. of cultures No. of clonesis the finding that the HPV-16 E5 does not constitutively
immortalized/ immortalized/activate the EGFR and requires the presence of ligand
Plasmida No. of expts. No. pickedfor biologic activity (20).
Because the HPV-16 E5 gene has been shown to coop- pSV2neo 0/6 0/18
erate with the E7 gene in the transformation of rodent pAT16E5X 3/4 9/12
pUC.ET16 3/3 9/9cells and due to the known mitogenic properties of HPV
pAT16 6/6 18/18E5 and its ability to interrupt cellular communication, we
pKV16E5 0/4 0/12chose to evaluate in this study if the E5 protein might alter
the human keratinocyte response to the E6/E7 genes. We a All plasmids were cotransfected with pSV2neo for G418 selection.
first evaluated whether wild-type and E5-mutant HPV-
16 genomes exhibited similar immortalizing activity. The
wild-type HPV-16 genome (pAT16) was modified by in- reduced numbers of clones immortalized with the pA-
T16E5X construct as described above led us to questionserting a translation termination linker at bp 3879 (con-
taining a unique XbaI site) in the E5 gene (pAT16E5X). whether E5 might modulate immortalization efficiency.
To measure the efficiency of immortalization, we used aThis insertion does not affect any other open reading
frame since the E5 ORF is nonoverlapping. Included in quantitative keratinocyte immortalization assay (7). In this
method primary keratinocytes were grown in 10-cmthese experiments were three additional plasmids: one
expressing the isolated E6 and E7 genes from the endo- dishes to 40% confluence in Keratinocyte Serum-Free
Medium (KSFM: Gibco-BRL), transfected with 10 mg plas-genous promoter (pUC.ET16), one expressing the HPV-
16 E5 gene alone downstream of the human cytomegalo- mid DNA using Lipofectin Reagent (Gibco-BRL), and cul-
tured until the cells reached confluency. Cells were thenvirus early gene promoter (pKV16E5), and a control vector
(pSV2neo). Primary human keratinocytes were grown passaged into 162-cm2 flasks and further cultured until
confluency. The cultures were then changed into Dulbec-from human foreskins in KGM medium (Clonetics, San
Diego, CA) and used at either first or second passage. co’s Modified Eagle Medium (DMEM) containing 10% fe-
tal calf serum and 1 mg/ml hydrocortisone and culturedCells were electroporated as previously described (6)
with the appropriate plasmid plus pSV2neo which con- for an additional 2–4 weeks. The change in medium
increases the serum and Ca2/ concentration which in-tains a selectable marker for neomycin resistance. Fol-
lowing electroporation the cells were placed in E media duces keratinocyte differentiation. Keratinocytes ex-
pressing the E6/E7 genes, however, display a resistanceplus 30 mg/ml G418 and cultured with NIH3T3 J2 feeder
cells. After 14 days of selection, six individual colonies to this induction and appear as ‘‘plaque-like’’, monolayer
colonies against a background of stratified, differentiatedfrom each transfection were cloned; three were immedi-
ately frozen and three were passaged for several months cells (Fig. 1). When quantitated, this assay showed that
the full-length HPV-16 genome (pAT16) was approxi-(at least 30 passages with 1:10 split ratios) to appraise
immortalization. The presence of the HPV genome in mately fivefold more efficient at immortalizing cells than
the pUC.ET16 vector expressing only the E6/E7 genesrepresentative clones from each transfection was evalu-
ated by Southern blotting (data not shown). Each clone (Table 2). In addition, plasmid pAT16E5X was also able
to immortalize cells (as expected from the previouscontained detectable integrated HPV DNA at a copy num-
ber of 5 or less, and Northern blots of these lines probed assay) but the efficiency was similar to that seen with
E6/E7 alone. Thus, the presence of an intact E5 gene inwith an HPV-16 E5 RNA probe have been described pre-
viously (29). All of the tested constructs, except pKV16E5 cis increases keratinocyte immortalization by the HPV-
16 genome. To confirm that the differentiation-resistantand pSV2neo, were capable of immortalizing keratino-
cytes (Table 1), although pAT16E5X did not immortalize colonies represented immortalized cells (as shown be-
fore (7)), we cloned three colonies from each of theall cultures or all clones evaluated. There were no differ-
ences in growth rates of the cell lines immortalized by dishes treated with pAT16 and pAT16E5X and passaged
them in E media. All the clones grew to passage levelspAT16, pAT16E5X, or pUC.ET16 (data not shown). Plas-
mid pKV16E5 was able to extend the life span of keratino- representative of an immortalized phenotype. To verify
that the reduced immortalization observed with pA-cytes but none became immortalized. In four experi-
ments, E5 was able to extend the life span of keratino- T16E5X was not the consequence of a reduction in HPV
oncoprotein expression, we examined pAT16-, pU-cytes to 20 passages while control cells differentiated
and died between the fifth and tenth passage. C.ET16-, and pAT16E5X-immortalized keratinocyte lines
by Northern blot analysis for E7 mRNA. E7 RNA levelsWhile the above study confirms that the E5 gene was
not essential for cell immortalization, the nonquantitative varied among different cell lines and were not correlated
with the presence of wild-type E5, indicating that de-nature of the assay and the suggestion that there were
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TABLE 2creased E7 expression was not responsible for the de-
crease in immortalization with pAT16E5X (data not Number of Immortalized Colonies
shown).
Number of immortalized coloniesTo evaluate whether the E5 gene could cooperate with
E6/E7 in trans, we cotransfected DNAs expressing the
Plasmida Expt. 1 Expt. 2 Expt. 3HPV-16 E5 gene under the control of the human cytomeg-
alovirus early gene promoter (pKV16E5), the Moloney pAT153b NDc 0 0
LTR promoter (pUCMo16E5), or an epitope-tagged HPV- pAT16E5X 8 4 2
pUC.ET16 13 2 516 E5 construct under the control of the SV40 early pro-
pAT16 33 50 25moter (pSG.R16E5) with the plasmid expressing the HPV-
16 E6 and E7 genes (pUC.ET16) into primary human kera- a 10 mg of each were used in the lipofection mix.
tinocytes in a DNA ratio of 4 or 5:1. We were unable to b Vector control.
demonstrate an increase in the number of immortalized c Not done.
colonies in the quantitative assay when E5 was cotrans-
fected with E6/E7 (data not shown). The inability of HPV-
acts synergistically with EGF to stimulate [3H]thymidine16 E5 expression in trans by various heterologous pro-
uptake (20). This apparently occurs because E5 inhibitsmoters to augment keratinocyte immortalization sug-
the normal down-regulation of the EGFR and causes in-gests that there may be a need to temporally or differen-
creased numbers of receptors on the cell surface andtially regulate E5 expression during immortalization with
increased phosphorylation of the receptor. Therefore thethe native HPV-16 LCR.
mitogenic stimulus caused by E5 may produce activelyThis study shows that the expression of E5 in cis by
growing cells which are more efficiently transformed thanits native promoter increases immortalization of the HPV
quiescent cells (31). This hypothesis is supported by thehost cell, the human keratinocyte, by HPV-16. E5 has
finding that E5 alone can significantly extend the life spanbeen shown to be a mitogen for keratinocytes and it
of normal keratinocytes. HPV E5-containing cell lines
may display insensitivity to growth regulatory signals via
impaired gap junctional communication (27). E5 may also
have an important role in establishing viral infection in
vivo. HPVs are small DNA viruses and rely on the replica-
tive system of the cells for production of new viral prog-
eny. An abundant mRNA capable of coding for E5 is
found in the parabasal cells of the epithelium where the
cells initiate terminal differentiation. One role for E5 might
be to induce proliferation rather than differentiation and
therefore expand the population of infected cells and
increase viral production.
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